Direct-to-Patient Registries: A New Approach to Pharmacovigilance

Direct-to-Patient Registries: A New Approach to Pharmacovigilance


Authored by: Nancy Dreyer, MPH, Ph.D., Global Chief of Scientific Affairs and Michelle Leavy, MPH, Manager, Health Policy, Quintiles

Published in: BioScience Technology – 28th October 2015

Industry thought-leader Nancy Dreyer reviews the latest thinking in pharmacovigilance and the promise of direct-to-patient registries. Nancy outlines Quintiles’ involvement in the PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) study and highlights that “with the rapid advance of technology, we have seen a number of non-traditional approaches to AE reporting cropping up… the web-based solution offered by MyMeds&Me offers an intuitive, standardized method of capturing AE data via SaaS. Patients can simply point and click on “where it hurts” to generate direct-from-patient data nearly instantly.”

Access the full article here

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing


We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.